Fig. 1

Local control rate (A), overall survival (B), disease free survival (C), local-regional recurrence free survival (D), distant metastasis free survival (E) of the enrolled patients in ESO-Shanghai 8 study (RT group) and this study (CRT group)
Local control rate (A), overall survival (B), disease free survival (C), local-regional recurrence free survival (D), distant metastasis free survival (E) of the enrolled patients in ESO-Shanghai 8 study (RT group) and this study (CRT group)